carmustine has been researched along with elliptinium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Habraken, Y; Laval, F | 1 |
| Ali-Osman, F; Dougherty, D; Giblin, J; Rosenblum, ML | 1 |
2 other study(ies) available for carmustine and elliptinium
| Article | Year |
|---|---|
Enhancement of 1,3-bis(2-chloroethyl)-1-nitrosourea resistance by gamma-irradiation or drug pretreatment in rat hepatoma cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Carmustine; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Radiation; Drug Resistance; Drug Synergism; Ellipticines; Gamma Rays; Liver Neoplasms; Methyltransferases; O(6)-Methylguanine-DNA Methyltransferase; Rats; Time Factors; Tumor Cells, Cultured | 1991 |
Application of in vivo and in vitro pharmacokinetics for physiologically relevant drug exposure in a human tumor clonogenic cell assay.
Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Biological Assay; Brain Neoplasms; Carmustine; Cell Line; Cisplatin; Clone Cells; Dose-Response Relationship, Drug; Ellipticines; Glioma; Half-Life; Humans; Mathematics; Streptozocin; Teniposide | 1987 |